Cite
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis.
MLA
Gatti, Milo, et al. “Clinical Efficacy of Cefiderocol-Based Regimens in Patients with Carbapenem-Resistant Acinetobacter Baumannii Infections: A Systematic Review with Meta-Analysis.” International Journal of Antimicrobial Agents, vol. 63, no. 2, Feb. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2023.107047.
APA
Gatti, M., Cosentino, F., Giannella, M., Viale, P., & Pea, F. (2024). Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis. International Journal of Antimicrobial Agents, 63(2), N.PAG. https://doi.org/10.1016/j.ijantimicag.2023.107047
Chicago
Gatti, Milo, Federica Cosentino, Maddalena Giannella, Pierluigi Viale, and Federico Pea. 2024. “Clinical Efficacy of Cefiderocol-Based Regimens in Patients with Carbapenem-Resistant Acinetobacter Baumannii Infections: A Systematic Review with Meta-Analysis.” International Journal of Antimicrobial Agents 63 (2): N.PAG. doi:10.1016/j.ijantimicag.2023.107047.